Yi-wei Huang
No. 7 Chung San South Road
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Topical rapamycin (sirolimus) for the treatment of facial discoid dermatosis.
Journal: European journal of dermatology : EJD
Published: June 22, 2024
Deficiency of interleukin-36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan.
Journal: Experimental dermatology
Published: December 30, 2022
Factors Associated With Quality Care Among Adults With Rheumatoid Arthritis.
Journal: JAMA network open
Published: December 12, 2022
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experience.
Journal: Expert review of clinical pharmacology
Published: July 18, 2022
Injection-Site Reaction to Brodalumab in a Psoriasis Patient: Report of Clinicopathological Findings.
Journal: The American Journal of dermatopathology
Published: March 02, 2022
Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review.
Journal: Dermatology and therapy
Published: January 31, 2022
Ethambutol-induced subacute cutaneous lupus erythematosus.
Journal: The Kaohsiung journal of medical sciences
Published: January 28, 2022
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center.
Journal: Frontiers in medicine
Published: November 09, 2021
A Celecoxib Derivative Eradicates Antibiotic-Resistant Staphylococcus aureus and Biofilms by Targeting YidC2 Translocase.
Journal: International journal of molecular sciences
Published: October 27, 2020
PhoPQ two-component regulatory system plays a global regulatory role in antibiotic susceptibility, physiology, stress adaptation, and virulence in Stenotrophomonas maltophilia.
Journal: BMC microbiology
Published: May 19, 2020
A drug safety evaluation of risankizumab for psoriasis.
Journal: Expert opinion on drug safety
Published: February 27, 2020
Last Updated: 09/26/2026